Lv1
60 积分 2023-05-12 加入
Vadadustat Three Times Weekly in Patients With Anemia Due to Dialysis-Dependent CKD
5天前
已完结
Hypertension Induced by Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitors in Treating Anemia in Patients With Chronic Kidney Disease: A Mini‐Review
11天前
已完结
Roxadustat protects oxidative stress and tissue injury in the brain induced by ischemic stroke via the HIF-1α/NRF2 axis
12天前
已完结
Roxadustat combined with immunosuppressants for treatment of pure red cell aplasia with kidney injury
12天前
已完结
[Almost Forty Years of Erythropoietin Therapy: Successes and Limitations]
12天前
已关闭
Roles of Hypoxia-Inducible Factor-Prolyl Hydroxylases in Aging and Disease
29天前
已完结
Roxadustat for Treating Anemia in Patients with Advanced Chronic Kidney Disease Not Undergoing Dialysis: A Retrospective Study
1个月前
已完结
Roxadustat for Treating Anemia in Patients with Advanced Chronic Kidney Disease Not Undergoing Dialysis: A Retrospective Study
1个月前
已关闭
Initial experiences with combined therapy of anemia with roxadustat and epoetin α in hemodialysis patients: a case series
1个月前
已完结
Roxadustat, an hypoxia-inducible factor-prolyl hydroxylase inhibitor induce sickle cell crisis: A case report
2个月前
已完结
皖公网安备34019202002308
